Drawing for E EMERALD CLINICAL

USPTO serial 79430852

E EMERALD CLINICAL

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
BERGER, MAGDALENA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with E EMERALD CLINICAL?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
016Paper and cardboard; printed matter, namely, journals in the field of clinical research, medicine, and healthcare; printed instructional and teaching materials in the field of clinical research, medicine, and healthcare; printed pamphlets in the field of clinical research, medicine, and healthcare; printed brochures in the field of clinical research, medicine, and healthcare; printed books in the field of clinical research, medicine, and healthcare; stationery; printed photographs; printed periodicals in the field of clinical research, medicine, and healthcare; bookbinding material, namely, binding strips for bookbinding; printed matter in the nature of reports, instructional, educational, teaching, and training material in the fields of conducting, managing, reporting, developing, education and analysis of clinical research, consumer healthcare and medicine; none of the foregoing being in the field of trade showsACTIVE
035Business management and business administration for others; providing office functions; professional business consultancy; business management and organization consultancy; business consulting in the field of clinical trials; provision of business administration services for others in the field of clinical research, consumer health and medicine; placement of personnel in the field of clinical research, consumer health and medicine, and all associated personnel management consulting; data management services for use in the field of clinical research, medicine, and healthcare; data processing services; data handling in the nature of data processing services; business consulting and management in the field of clinical research; business administrative services for medical referrals; information, consultancy and advisory services relating to the aforementioned servicesACTIVE
041Educational services, namely, conducting classes, seminars, conferences, and workshops in the field of clinical research, medicine, and healthcare; providing training in the field of clinical research, medicine, and healthcare; provision of educational information in the field of education regarding clinical research, medicine, and healthcare; publication of journals, pamphlets, brochures, books, periodicals, and articles in the field of results of clinical trials; publication of journals, pamphlets, brochures, books, periodicals, and articles in the field of results of clinical trials for pharmaceutical preparations; providing online non-downloadable electronic publications in the nature of articles, blog posts, case studies, and e-learning modules being teaching materials in the field of medicine and healthcare; e-learning and distance learning services being educational services, namely, conducting classes, seminars, conferences, and workshops in the field of clinical research, medicine, and healthcare; preparation and presentation of e-learning programs, namely, developing, arranging, and conducting educational conferences and programs in the field of clinical research, medicine, and healthcare; education and training, namely, e-learning and learning in the nature of conducting classes, seminars, conferences, and workshops in the field of clinical research, medicine, and healthcare by the temporary use of non-downloadable online software for education and training; arranging and conducting of seminars in the field of clinical research, medicine, and healthcare; event hosting services, namely, hosting social entertainment events; entertainment in the nature of hosting social entertainment events; arranging and conducting of workshops and training in the field of clinical research, medicine, and healthcare; arranging and conducting of in-person educational forums in the field of clinical research, medicine, and healthcare; provision of training and education in the nature of classes, seminars, conferences, and workshops related to the conduct, management, reporting, development and analysis of clinical research, consumer health and medicine; organization of exhibitions for cultural or educational purposes; providing practical training being educational demonstration in the field of clinical research, medicine, and healthcare; providing online electronic publications, not downloadable in the nature of journals, pamphlets, brochures, books, periodicals, and articles in the field of clinical research, medicine, and healthcare; information, consultancy and advisory services relating to the aforementioned servicesACTIVE
042Scientific research; medical and scientific research, namely, conducting clinical trials for others; scientific research relating to clinical trials; conducting clinical trials for others in the field of pharmaceuticals; providing medical and scientific research information about the results of clinical trials for pharmaceuticals; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; software development for clinical trials; software as a service (SAAS) services featuring software for conducting and analyzing clinical trials; software development in the framework of software publishing; software engineering services for data processing; scientific research and development services in the field of clinical trials; scientific and technological services, namely, research, design and analysis services related to the conduct, management, reporting, development, education and analysis of clinical research, consumer health and medicine; design and development of computer software and hardware for the conduct, management, reporting, development, education and analysis of clinical research, consumer health and medicine; information, consultancy and advisory services relating to the aforementioned services; none of the foregoing being in the field of addiction treatment or drug addiction rehabilitationACTIVE
044Medical services; medical consultations; healthcare consultancy services; medical consultancy services; preparation of reports relating to healthcare, namely, medical reporting services; medical information services provided via the internet; providing medical information; medical healthcare consultancy services; advisory and consultancy services relating to healthcare; healthcare services, namely, providing pharmacovigilance support in the nature of information, advisory and consultancy services in the field of pharmacovigilance to healthcare professionals; providing healthcare information; medical and healthcare services, namely, providing medical consulting services to healthcare providers and patients in the field of clinical trials; wellness services being consulting services in the fields of health and nutrition; wellness and health-related assessment services; health assessment services; providing information in the fields of health and wellness; health care services, namely, wellness programs; consumer health consultancy and providing information in the field of medicine; medical analysis services relating to the treatment of persons; remote monitoring of medical data for medical diagnosis and treatment; medical examination; medical screening; medical treatment using cultured cells; medical health services being medical services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical consultations, namely, clinical medicine consultation services; information, consultancy and advisory services relating to the aforementioned services; none of the foregoing being in the field of addiction treatment or drug addiction rehabilitationACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 18, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Aug 18, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 12, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jul 23, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Jul 23, 2026GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jul 23, 2026XAECEXAMINER'S AMENDMENT ENTERED
Jul 23, 2026GNEAEXAMINERS AMENDMENT E-MAILED
Jul 23, 2026CNEAEXAMINERS AMENDMENT -WRITTEN
Jul 16, 2026GNFNNOTIFICATION OF FINAL REFUSAL EMAILED
Jul 16, 2026GNFRFINAL REFUSAL E-MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jul 16, 2026CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Apr 2, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Apr 2, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 2, 2026TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 31, 2025RFNTREFUSAL PROCESSED BY IB
Oct 15, 2025RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Oct 15, 2025RFRRREFUSAL PROCESSED BY MPU
Aug 30, 2025RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 29, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 26, 2025DOCKASSIGNED TO EXAMINER
Aug 25, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Aug 25, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 21, 2025REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance